MCL1 and acute myeloid leukemia: To determine whether OTS167 downregulated the expression of other oncoproteins implicated in AML, expression of c-Myc and MCL-1 was also assessed after 50 nM OTS167 treatment in primary human FLT3 mutant cells (Fig. 1C and Table 1).